logo image

HIV Molecular Immunology Database

Patient Detail

Patient Code VID418 (418)
Patient Sex
Risk Factor
Infection Country
Infection City
Infection Year
HLA Type A*02:01, A*24:02, B*07:02, B*27:05, C*01:02, C*07:02, DQB1*03:01, DQB1*03:03, DRB1*04:01, DRB1*07:01, DRB4
Patient Ethnicity
Progression
Species human
Patient Note Volunteer ID 418 is a healthy HIV-negative subject who was administered the first generation of HIVconsv vaccine, and whose PBMC responded to the peptides annotated above (DDDCM, where D = pSG2.HIVconsv; C = ChAdV63.HIVconsv, 5x1010 virus particles; M = MVA.HIVconsv 2x10 plaque forming units), and whose PBMC responded to the peptides annotated above with a peak EliSpot against CD4+ T cell epitopes of 7060 SFU/106 PBMC. [Borthwick2017CTL, PMID: 28448594 & Borthwick2020HTL, PMID: 31963212].
CTL CD8+ Records 61824, 61833, 61834
T-Helper CD4+ Records 201947, 201948, 201949, 201950, 201951, 201952, 201953, 201954, 201955, 201956, 201957, 201958
Antibody Records
Sequence Database Patient ID Record
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
Copyright Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services LANL logo National Institutes of Health logo